vs
Princeton Bancorp, Inc.（BPRN）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Princeton Bancorp, Inc.的1.7倍（$35.5M vs $20.7M），Princeton Bancorp, Inc.净利率更高（29.3% vs -304.2%，领先333.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.6%），Princeton Bancorp, Inc.自由现金流更多（$20.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 9.1%）
普林斯顿银行控股公司是一家总部位于美国的银行控股企业，通过旗下社区银行子公司开展业务，提供零售与商业银行全品类服务，包括存款账户、中小企业贷款、个人消费贷款、抵押贷款及财富管理服务，主要服务新泽西州及美国中大西洋地区客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BPRN vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.7M | $35.5M |
| 净利润 | $6.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 38.2% | -304.8% |
| 净利率 | 29.3% | -304.2% |
| 营收同比 | 3.6% | 681.7% |
| 净利润同比 | 16.3% | 39.6% |
| 每股收益（稀释后） | $0.89 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $20.7M | $35.5M | ||
| Q3 25 | $21.5M | $5.2M | ||
| Q2 25 | $21.1M | $19.2M | ||
| Q1 25 | $20.9M | $14.7M | ||
| Q4 24 | $20.0M | $4.5M | ||
| Q3 24 | $19.2M | $26.1M | ||
| Q2 24 | $18.1M | $14.4M | ||
| Q1 24 | $17.4M | $13.8M |
| Q4 25 | $6.1M | $-108.1M | ||
| Q3 25 | $6.5M | $-162.3M | ||
| Q2 25 | $688.0K | $-171.9M | ||
| Q1 25 | $5.4M | $-202.5M | ||
| Q4 24 | $5.2M | $-178.9M | ||
| Q3 24 | $-4.5M | $-95.8M | ||
| Q2 24 | $5.1M | $-97.5M | ||
| Q1 24 | $4.3M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 38.2% | -304.8% | ||
| Q3 25 | 38.5% | -3327.6% | ||
| Q2 25 | 2.8% | -916.8% | ||
| Q1 25 | 32.9% | -1297.9% | ||
| Q4 24 | 34.0% | -4042.4% | ||
| Q3 24 | -29.1% | -377.1% | ||
| Q2 24 | 34.1% | -697.4% | ||
| Q1 24 | 31.0% | -698.4% |
| Q4 25 | 29.3% | -304.2% | ||
| Q3 25 | 30.0% | -3135.3% | ||
| Q2 25 | 3.3% | -894.2% | ||
| Q1 25 | 25.7% | -1373.3% | ||
| Q4 24 | 26.1% | -3935.5% | ||
| Q3 24 | -23.3% | -367.5% | ||
| Q2 24 | 28.4% | -676.6% | ||
| Q1 24 | 24.9% | -662.4% |
| Q4 25 | $0.89 | $-0.17 | ||
| Q3 25 | $0.95 | $-0.36 | ||
| Q2 25 | $0.10 | $-0.41 | ||
| Q1 25 | $0.77 | $-0.50 | ||
| Q4 24 | $0.75 | $-0.56 | ||
| Q3 24 | $-0.68 | $-0.34 | ||
| Q2 24 | $0.80 | $-0.40 | ||
| Q1 24 | $0.68 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $270.7M | $1.1B |
| 总资产 | $2.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $0 | $11.9M | ||
| Q2 25 | $10.0M | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $0 | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $270.7M | $1.1B | ||
| Q3 25 | $266.6M | $1.0B | ||
| Q2 25 | $261.9M | $919.1M | ||
| Q1 25 | $267.0M | $933.9M | ||
| Q4 24 | $262.0M | $1.0B | ||
| Q3 24 | $261.5M | $524.6M | ||
| Q2 24 | $244.8M | $584.4M | ||
| Q1 24 | $241.8M | $401.2M |
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.3B | $1.3B | ||
| Q4 24 | $2.3B | $1.4B | ||
| Q3 24 | $2.4B | $726.5M | ||
| Q2 24 | $2.0B | $775.9M | ||
| Q1 24 | $2.0B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.00× | 0.01× | ||
| Q2 25 | 0.04× | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.00× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $20.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 99.3% | -133.1% |
| 资本支出强度资本支出/营收 | 4.3% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.54× | — |
| 过去12个月自由现金流最近4个季度 | $29.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $21.5M | $-46.1M | ||
| Q3 25 | $4.9M | $-117.4M | ||
| Q2 25 | $3.1M | $-76.4M | ||
| Q1 25 | $1.3M | $-132.0M | ||
| Q4 24 | $14.7M | $-115.4M | ||
| Q3 24 | $1.2M | $-59.2M | ||
| Q2 24 | $4.3M | $-82.2M | ||
| Q1 24 | $4.8M | $-102.3M |
| Q4 25 | $20.6M | $-47.3M | ||
| Q3 25 | $4.7M | $-117.6M | ||
| Q2 25 | $2.9M | $-79.6M | ||
| Q1 25 | $1.1M | $-133.8M | ||
| Q4 24 | $13.2M | $-116.7M | ||
| Q3 24 | $766.0K | $-63.8M | ||
| Q2 24 | $3.9M | $-83.4M | ||
| Q1 24 | $4.8M | $-109.0M |
| Q4 25 | 99.3% | -133.1% | ||
| Q3 25 | 21.6% | -2272.5% | ||
| Q2 25 | 13.7% | -413.9% | ||
| Q1 25 | 5.0% | -907.4% | ||
| Q4 24 | 65.9% | -2567.7% | ||
| Q3 24 | 4.0% | -244.6% | ||
| Q2 24 | 21.8% | -578.5% | ||
| Q1 24 | 27.3% | -789.9% |
| Q4 25 | 4.3% | 3.5% | ||
| Q3 25 | 1.1% | 4.7% | ||
| Q2 25 | 1.2% | 16.4% | ||
| Q1 25 | 1.0% | 12.4% | ||
| Q4 24 | 7.6% | 28.6% | ||
| Q3 24 | 2.2% | 17.5% | ||
| Q2 24 | 2.1% | 8.2% | ||
| Q1 24 | 0.4% | 48.2% |
| Q4 25 | 3.54× | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 4.57× | — | ||
| Q1 25 | 0.23× | — | ||
| Q4 24 | 2.82× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
